Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medtronic, a medical technology company, has announced the acquisition of Ventor Technologies, a developer of transcatheter heart valve technologies for the treatment of aortic valve disease, for $325 million.
Subscribe to our email newsletter
Medtronic said that this acquisition adds two technologies to its transcatheter valve portfolio: a minimally invasive, surgical transapical technology and a next generation percutaneous, transfemoral technology. These complementary technologies offer compelling clinical benefit to distinctly different subsets of patients with aortic stenosis who are at high or prohibitive risk for surgery, added Medtronic.
Bill Hawkins, chairman and CEO of Medtronic, said: “The combination of Ventor Technologies and our strengths in R&D, operations, medical education and market development will improve patient outcomes and expand physician adoption among both surgeons and interventional cardiologists.”